Ars Pharmaceuticals, Inc.
Clinical trials sponsored by Ars Pharmaceuticals, Inc., explained in plain language.
-
No-Needle allergy rescue? nasal spray tested against standard shot
Disease control Recruiting nowThis study is testing whether a needle-free nasal spray called neffy is as safe and effective as a standard epinephrine shot for treating allergic reactions. It will involve 600 people, including children, who have a reaction during planned food or allergy testing. The goal is to…
Phase: PHASE4 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug trial offers hope for chronic hives sufferers
Symptom relief Recruiting nowThis study is testing whether a medication called ARS-2 can reduce itching and hives in adults with chronic spontaneous urticaria (long-term hives with no clear cause). Participants will receive either ARS-2 or a placebo during their hives flare-ups to compare effectiveness. The …
Phase: PHASE2 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC